Position
Bridgewater in Adma Biologics, Inc.
Back to the book · All holders of ADMA
Estimated mark uses implied 13F prices (value ÷ shares). Adds are treated as happening at this quarter’s mark; cuts at last quarter’s. Share jumps can be splits, not buys. This is not realized P&L.
Latest estimated mark −$256.7K$9.01 → $8.37
| Quarter | Shares | Value | Implied px | Est. mark | Flow | Weight |
|---|---|---|---|---|---|---|
| Q4 2025 | 186.5K | $3.4M | — | — | — | 0.0% |
| Q1 2026 | 472.1K | $4.25M | $9.01 | −$1.72M | $2.57M | 0.0% |
| Q2 2026 | 401.1K | $3.36M | $8.37 | −$256.7K | −$640.2K | 0.0% |